Literature DB >> 18956256

Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice.

Ming-Jia Niu1, Jin-Kui Yang, Shan-Shan Lin, Xiu-Juan Ji, Li-Min Guo.   

Abstract

This study aimed to investigate the role of angiotensin-converting enzyme 2 (ACE2) in regulating glucose homeostasis. Immunohistochemistry was used to investigate ACE2 expression in the pancreas. Glucose tolerance test, insulin secretion test, and insulin tolerance test were performed in age-matched male ACE2 knockout (KO) and wild-type (WT) mice. We found that ACE2 was positively expressed in the pancreas. Male ACE2 KO mice displayed a selective decrease in first-phase insulin secretion in response to glucose and a progressive impairment of glucose tolerance compared with age- and sex-matched WT mice. On the other hand, insulin sensitivity of the peripheral tissue in age-matched ACE2 KO and WT mice showed no difference. These findings suggest that ACE2 might play an important role in glucose homeostasis as well as type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18956256     DOI: 10.1007/s12020-008-9110-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  31 in total

1.  Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients.

Authors:  M Anello; R Lupi; D Spampinato; S Piro; M Masini; U Boggi; S Del Prato; A M Rabuazzo; F Purrello; P Marchetti
Journal:  Diabetologia       Date:  2005-01-15       Impact factor: 10.122

2.  Angiotensin-converting enzyme 2 (ACE2) and ACE activities display tissue-specific sensitivity to undernutrition-programmed hypertension in the adult rat.

Authors:  Guillaume Rivière; Annie Michaud; Christophe Breton; Gilles VanCamp; Christine Laborie; Mihaela Enache; Jean Lesage; Sylvie Deloof; Pierre Corvol; Didier Vieau
Journal:  Hypertension       Date:  2005-10-03       Impact factor: 10.190

3.  Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

Authors:  Minghao Ye; Jan Wysocki; Josette William; Maria José Soler; Ivan Cokic; Daniel Batlle
Journal:  J Am Soc Nephrol       Date:  2006-10-04       Impact factor: 10.121

4.  Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.

Authors:  Hussam Abuissa; Philip G Jones; Steven P Marso; James H O'Keefe
Journal:  J Am Coll Cardiol       Date:  2005-09-06       Impact factor: 24.094

5.  Contribution of angiotensin II to late renal injury after acute ischemia.

Authors:  Maria Enrica Pagtalunan; Jean L Olson; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2000-07       Impact factor: 10.121

6.  Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis.

Authors:  H Peters; W A Border; N A Noble
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

7.  Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Authors:  Stevo Julius; Sverre E Kjeldsen; Michael Weber; Hans R Brunner; Steffan Ekman; Lennart Hansson; Tsushung Hua; John Laragh; Gordon T McInnes; Lada Mitchell; Francis Plat; Anthony Schork; Beverly Smith; Alberto Zanchetti
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

Review 8.  Angiotensin II as a pro-inflammatory mediator.

Authors:  M Ian Phillips; Shuntaro Kagiyama
Journal:  Curr Opin Investig Drugs       Date:  2002-04

9.  Angiotensin II- and glucose-stimulated extracellular matrix production: mediation by the insulin-like growth factor (IGF) axis in a murine mesangial cell line.

Authors:  Lori K Davis; Buel D Rodgers; Kevin M Kelley
Journal:  Endocrine       Date:  2008-04-08       Impact factor: 3.633

10.  Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat.

Authors:  Christos Tikellis; Peter J Wookey; Riccardo Candido; Sof Andrikopoulos; Merlin C Thomas; Mark E Cooper
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

View more
  45 in total

Review 1.  ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

Authors:  Ping Xu; Srinivas Sriramula; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-22       Impact factor: 3.619

2.  Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.

Authors:  Yang Zhang; Jian Liu; Jiang-Yun Luo; Xiao Yu Tian; Wai San Cheang; Jian Xu; Chi Wai Lau; Li Wang; Wing Tak Wong; Chi Ming Wong; Hui Yao Lan; Xiaoqiang Yao; Mohan K Raizada; Yu Huang
Journal:  Antioxid Redox Signal       Date:  2015-05-14       Impact factor: 8.401

3.  The renin angiotensin system and the metabolic syndrome.

Authors:  Chih-Hong Wang; Feng Li; Nobuyuki Takahashi
Journal:  Open Hypertens J       Date:  2010

Review 4.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

5.  ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice.

Authors:  Robin Shoemaker; Frederique Yiannikouris; Sean Thatcher; Lisa Cassis
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-08-04       Impact factor: 4.310

6.  ACE2 and diabetes: ACE of ACEs?

Authors:  Daniel Batlle; Maria Jose Soler; Minghao Ye
Journal:  Diabetes       Date:  2010-12       Impact factor: 9.461

Review 7.  Angiotensin converting enzyme 2: a new important player in the regulation of glycemia.

Authors:  Kavaljit H Chhabra; Harshita Chodavarapu; Eric Lazartigues
Journal:  IUBMB Life       Date:  2013-07-29       Impact factor: 3.885

8.  The transcription factor HNF1α induces expression of angiotensin-converting enzyme 2 (ACE2) in pancreatic islets from evolutionarily conserved promoter motifs.

Authors:  Kim Brint Pedersen; Kavaljit H Chhabra; Van K Nguyen; Huijing Xia; Eric Lazartigues
Journal:  Biochim Biophys Acta       Date:  2013-10-05

9.  Oral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats.

Authors:  Sérgio H S Santos; Jorge F Giani; Valeria Burghi; Johanna G Miquet; Fatimunnisa Qadri; Janaina F Braga; Mihail Todiras; Katarina Kotnik; Natalia Alenina; Fernando P Dominici; Robson A S Santos; Michael Bader
Journal:  J Mol Med (Berl)       Date:  2013-10-27       Impact factor: 4.599

10.  Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice.

Authors:  Kavaljit H Chhabra; Huijing Xia; Kim Brint Pedersen; Robert C Speth; Eric Lazartigues
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-05       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.